Manual Lymphatic Drainage in the Superior Member in Women in Post-surgery for Breast Cancer

NCT ID: NCT02475174

Last Updated: 2015-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate the effect of Manual Lymphatic Drainage (MLD) massage in arterial and venous circulation of the upper limb ipsilateral of women submitted after axillary lymphadenectomy breast cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to evaluate the effect of Manual Lymphatic Drainage (MLD) massage in arterial and venous circulation of the upper limb ipsilateral of women submitted after axillary lymphadenectomy breast cancer. Will be evaluated 30 volunteers aged between 40 and 60 years, divided into 2 equal groups, submitted at MLD: Group 1 - volunteers who underwent surgery for breast cancer that have lymphedema, subject to manual lymphatic drainage without upper limb elevation; Group 2 - volunteers who underwent surgery for breast cancer that have lymphedema, subject to manual lymphatic drainage with the upper limb elevation to 30º. Data will be collected by ultrasound Doppler in vein and brachial artery before, after MLD, immediately after, and 30 minutes after therapeutic treatment, with and without elevation of 30°, cross over delimitation, being made a therapy session for therapeutic use with and without elevation, with interval period (washout) for seven days. The order of treatment protocols will be randomized by simple raffle for each volunteer. The data within and between groups will be evaluated by a statistical test t student or ANOVA. Otherwise it will be used Kruskal-Wallis followed test by Dunn. Data processing will be performed by software and fixed the critical level of 5% (p\<0,05).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphedema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Without upper limb elevation

Manual lymphatic drainage will be held with the voluntary supine without upper limb elevation.

Group Type EXPERIMENTAL

Without upper limb elevation

Intervention Type OTHER

Lymphatic drainage without elevation of the upper limb.

Upper limb elevation to 30º

Manual lymphatic drainage will be held with the voluntary supine with the upper limb elevation to 30º.

Group Type EXPERIMENTAL

Upper limb elevation to 30º

Intervention Type OTHER

Lymphatic drainage with elevation of the upper limb to 30º.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Without upper limb elevation

Lymphatic drainage without elevation of the upper limb.

Intervention Type OTHER

Upper limb elevation to 30º

Lymphatic drainage with elevation of the upper limb to 30º.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women with axillary lymphadenectomy surgery
* Lymphedema
* Aged 40-60 years.

Exclusion Criteria

* Women with muscle-tendon injury and / or joint injuries member
* Skin disorders
* circulatory diseases.
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Elaine Caldeira de Oliveira Guirro

Lais Mara Siqueira das Neves

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Elaine Guirro

Role: CONTACT

(16)3315-0215

Lais Neves

Role: CONTACT

(16) 3315-0215

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HCRP nº 13408/2013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.